Just as the title of the episode indicates, Vaxart stock is on the rise after breaking out of the pennant pattern it has been in for some time now. As I mentioned in previous episodes, VXRT’s share price has been getting squeezed between ever narrowing highs and lows for a while and over the last couple days has broken past resistance and is testing a new support level. Bag holders like you and I know that this break above resistance will let the stock to continue to push higher as volume continues to move into the stock. Ready to talk Vaxart? Let’s go.

Welcome to Money Talkz, the gems I drop between the weekly Money Talk Sundayz podcast. I’m your investment bro Stevie Bee. Special shout out to all the new subs. I appreciate all of you. You know the business, run that like, share, and subscribe. If you’re a VXRT holder you definitely want to sub. This is a special edition of our Vaxart Watch.

Let’s get it.

As you can see on the chart, VXRT is making moves and breaking past its resistance level. You know how they say today’s price is not tomorrow’s price? Well yesterday’s resistance is today’s support for Vaxart. Things are trending favorably and now is definitely a time to grab up more shares of Vaxart before you get priced out.

The stock is trading above both the 50-day moving average (which is the green line there) and the 200-day moving average (which is the blue line there), indicating sentiment in the stock looks to be turning bullish. Each of these moving averages may hold as a possible area of support in the future. The Relative Strength Index (RSI) has pushed higher the past few days and now sits at 62 on the indicator. What this means is that buying pressure is strongly outweighing the selling pressure in the stock.

Ignore the FUD (fear, uncertainty, doubt)!!!! Focus on the facts!!! Vaxart is a winner! Moderna CEO has already come out saying that the current vaccines out are less effective against the new Omicron Covid variant. Vaccine resistance could lead to more sickness and hospitalizations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks, and the Australian dollar.

We are anticipating even higher lows for VXRT. Over the next several days expect to see above average trading volume for Vaxart stock. Barring some crazy news expect the stock to remain above the moving averages. Stay bullish bros nation!

In press news, Vaxart, Inc. announced that the company’s vice president, Sean Tucker, will attend and speak at the World Vaccine & Immunotherapy Congress West Coast 2021, being held today. As of this recording it hasn’t happened yet, but I will let Bros Nation know how it goes.

It’s part of an award-winning series of conferences and exhibitions that’s steadily rising to become the world’s largest and most established vaccination events. Vaxart’s CSO will discuss the company’s research program for an oral candidate for the COVID-19 vaccine in the form of tablets. The medicine that needs to be swallowed against coronavirus is the only oral vaccine of its kind against COVID-19, which has immunological potential, which is confirmed. And this is the only vaccine that has been conducting Phase 2 clinical trials since October 2021.

If you haven’t done so, as a shareholder it is in your best interest to go to Vaxart.com and subscribe to their alerts.